{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:54:03Z","timestamp":1780707243841,"version":"3.54.1"},"reference-count":100,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T00:00:00Z","timestamp":1636675200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.ad.2021.11.002","type":"journal-article","created":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T01:47:28Z","timestamp":1637027248000},"page":"563-574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Prurigo cr\u00f3nico: actualizaci\u00f3n"],"prefix":"10.1016","volume":"113","author":[{"given":"A.","family":"Docampo-Sim\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"S\u00e1nchez-Pujol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.F.","family":"Silvestre-Salvador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2021.11.002_bib0510","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3477","article-title":"Exploring the EQ-5D dimension of pain\/discomfort in dermatology outpatients from a multicentre study in 13 European countries","author":"Sampogna","year":"2020","journal-title":"Acta Derm Venereol."},{"key":"10.1016\/j.ad.2021.11.002_bib0515","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jaad.2018.04.044","article-title":"Humanistic burden of chronic pruritus in patients with inflammatory dermatoses: Results of the European Academy of Dermatology and Venereology Network on Assessment of Severity and Burden of Pruritus (PruNet) cross-sectional trial","volume":"79","author":"Steinke","year":"2018","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2021.11.002_bib0520","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/jdv.15145","article-title":"The self-assessed psychological comorbidities of prurigo in European patients: A multicentre study in 13 countries","volume":"33","author":"Brenaut","year":"2019","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.ad.2021.11.002_bib0525","doi-asserted-by":"crossref","DOI":"10.1111\/bjd.18925","article-title":"Healthcare resource utilization and payer cost analysis of patients with prurigo nodularis","author":"Huang","year":"2020","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2021.11.002_bib0530","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1111\/jdv.15107","article-title":"Prurigo nodularis: A physician survey to evaluate current perceptions of its classification, clinical experience and unmet need","volume":"32","author":"Pereira","year":"2018","journal-title":"J Eur Acad Dermatology Venereol."},{"key":"10.1016\/j.ad.2021.11.002_bib0535","unstructured":"Real Academia Espa\u00f1ola. Diccionario de la lengua espa\u00f1ola, 23.a ed. [versi\u00f3n 23.3 en l\u00ednea] [acceso 27 Feb 2020]. Disponible en: https:\/\/dle.rae.es\/"},{"key":"10.1016\/j.ad.2021.11.002_bib0540","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1111\/exd.13972","article-title":"How to define chronic prurigo?","volume":"28","author":"Pereira","year":"2019","journal-title":"Exp Dermatol."},{"key":"10.1016\/j.ad.2021.11.002_bib0545","unstructured":"Bateman T, Willan R, Thompson A. A practical synopsis of cutaneous diseases: according to the arrangement of Dr Willan; exhibiting a concise view of the diagnostic symptoms and the method of treatment. 7th ed. Thomson AT, editor. London: Longman, Rees, Orme, Brown, and Green; 1829."},{"key":"10.1016\/j.ad.2021.11.002_bib0550","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s00105-014-2752-0","article-title":"[Nihil certum: Historical development of the term prurigo]","volume":"65","author":"Sch\u00fcrmann","year":"2014","journal-title":"Hautarzt."},{"key":"10.1016\/j.ad.2021.11.002_bib0555","doi-asserted-by":"crossref","DOI":"10.1111\/1346-8138.15212","article-title":"Chronic prurigo: A retrospective study of 168 cases","author":"Inui","year":"2020","journal-title":"J Dermatol."},{"key":"10.1016\/j.ad.2021.11.002_bib0560","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/jdv.14570","article-title":"European Academy of Dermatology and Venereology European prurigo project: Expert consensus on the definition, classification and terminology of chronic prurigo","volume":"32","author":"Pereira","year":"2018","journal-title":"J Eur Acad Dermatology Venereol."},{"key":"10.1016\/j.ad.2021.11.002_bib0565","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/jdv.15275","article-title":"Position statement: Linear prurigo is a subtype of chronic prurigo","volume":"33","author":"Pereira","year":"2019","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.ad.2021.11.002_bib0570","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jid.2019.07.697","article-title":"Real-world prevalence of prurigo nodularis and burden of associated diseases","volume":"140","author":"Huang","year":"2020","journal-title":"J Invest Dermatol."},{"key":"10.1016\/j.ad.2021.11.002_bib0575","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1468-3083.2012.04481.x","article-title":"Prurigo as a symptom of atopic and non-atopic diseases: Aetiological survey in a consecutive cohort of 108 patients","volume":"27","author":"Iking","year":"2013","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.ad.2021.11.002_bib0580","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jaad.2018.04.047","article-title":"Ethnic differences and comorbidities of 909 prurigo nodularis patients","volume":"79","author":"Boozalis","year":"2018","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2021.11.002_bib0585","author":"Song","year":"2018","journal-title":"Pruritus: Progress toward pathogenesis and treatment"},{"key":"10.1016\/j.ad.2021.11.002_bib0590","doi-asserted-by":"crossref","first-page":"90","DOI":"10.5826\/dpc.0902a03","article-title":"The itch-scratch cycle: A review of the mechanisms","author":"Rinaldi","year":"2019","journal-title":"Dermatol Pract Concept."},{"key":"10.1016\/j.ad.2021.11.002_bib0595","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s13238-017-0395-5","article-title":"TRPV1 and TRPA1 in cutaneous neurogenic and chronic inflammation: Pro-inflammatory response induced by their activation and their sensitization","volume":"8","author":"Gouin","year":"2017","journal-title":"Protein Cell."},{"key":"10.1016\/j.ad.2021.11.002_bib0600","first-page":"37","article-title":"The pathogenesis of prurigo nodularis - \u00abSuper-Itch\u00bb in exploration","volume":"20","author":"Zeidler","year":"2016","journal-title":"Eur J Pain (United Kingdom)."},{"key":"10.1016\/j.ad.2021.11.002_bib0605","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.det.2018.02.003","article-title":"Prurigo nodularis and its management","volume":"36","author":"Zeidler","year":"2018","journal-title":"Dermatol Clin."},{"key":"10.1016\/j.ad.2021.11.002_bib0610","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1365-2133.2011.10306.x","article-title":"Reduced intraepidermal nerve fibre density in lesional and nonlesional prurigo nodularis skin as a potential sign of subclinical cutaneous neuropathy","volume":"165","author":"Schuhknecht","year":"2011","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2021.11.002_bib0615","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/exd.13343","article-title":"There is no functional small-fibre neuropathy in prurigo nodularis despite neuroanatomical alterations","volume":"26","author":"Pereira","year":"2017","journal-title":"Exp Dermatol."},{"key":"10.1016\/j.ad.2021.11.002_bib0620","doi-asserted-by":"crossref","first-page":"404","DOI":"10.2340\/00015555-2232","article-title":"Intraepidermal nerve fibre density is decreased in lesional and inter-lesional prurigo nodularis and reconstitutes on healing of lesions","volume":"96","author":"Bobko","year":"2016","journal-title":"Acta Derm Venereol."},{"key":"10.1016\/j.ad.2021.11.002_bib0625","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jdermsci.2015.02.021","article-title":"Th2 cytokines enhance TrkA expression, upregulate proliferation, and downregulate differentiation of keratinocytes","volume":"78","author":"Matsumura","year":"2015","journal-title":"J Dermatol Sci."},{"key":"10.1016\/j.ad.2021.11.002_bib0630","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1365-2133.2011.10498.x","article-title":"Nuclear localization of activated STAT6 and STAT3 in epidermis of prurigo nodularis","volume":"165","author":"Fukushi","year":"2011","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2021.11.002_bib0635","doi-asserted-by":"crossref","first-page":"5318","DOI":"10.3390\/ijms22105318","article-title":"Substance p serves as a balanced agonist for mrgprx2 and a single tyrosine residue is required for \u03b2-arrestin recruitment and receptor internalization","volume":"22","author":"Ayudhya","year":"2021","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.ad.2021.11.002_bib0640","first-page":"291","article-title":"Substance P- and antigen-induced release of leukotriene B4, prostaglandin D2 and histamine from guinea pig skin by different mechanisms in vitro","author":"Furutani","year":"1999","journal-title":"Arch Dermatol Res."},{"key":"10.1016\/j.ad.2021.11.002_bib0645","first-page":"9","article-title":"Substance P induction of murine keratinocyte PAM 212 interleukin 1 production is mediated by the neurokinin 2 receptor (NK-2R)","author":"Song","year":"2000","journal-title":"Exp Dermatol."},{"key":"10.1016\/j.ad.2021.11.002_bib0650","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jaci.2016.12.980","article-title":"Substance P activates Mas-related G protein-coupled receptors to induce itch","volume":"140","author":"Azimi","year":"2017","journal-title":"J Allergy Clin Immunol."},{"key":"10.1016\/j.ad.2021.11.002_bib0655","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jaci.2005.10.033","article-title":"IL-31: A new link between T cells and pruritus in atopic skin inflammation","volume":"117","author":"Sonkoly","year":"2006","journal-title":"J Allergy Clin Immunol."},{"key":"10.1016\/j.ad.2021.11.002_bib0660","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jaci.2013.10.048","article-title":"A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: Involvement of TRPV1 and TRPA1","volume":"133","author":"Cevikbas","year":"2014","journal-title":"J Allergy Clin Immunol."},{"key":"10.1016\/j.ad.2021.11.002_bib0665","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1600-0560.2009.01484.x","article-title":"Prurigo nodularis: Systematic analysis of 58 histological criteria in 136 patients","volume":"37","author":"Weigelt","year":"2010","journal-title":"J Cutan Pathol."},{"key":"10.1016\/j.ad.2021.11.002_bib0670","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/1346-8138.12844","article-title":"Dermoscopy of prurigo nodularis","volume":"42","author":"Errichetti","year":"2015","journal-title":"J Dermatol."},{"key":"10.1016\/j.ad.2021.11.002_bib0675","doi-asserted-by":"crossref","first-page":"341","DOI":"10.4103\/ijd.IJD_123_18","article-title":"Role of dermoscopy in the diagnosis of hypertrophic lichen planus and prurigo nodularis","volume":"64","author":"Hanumaiah","year":"2019","journal-title":"Indian J Dermatol."},{"key":"10.1016\/j.ad.2021.11.002_bib0680","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5826\/dpc.0602a03","article-title":"Hypertrophic lichen planus versus prurigo nodularis: A dermoscopic perspective","volume":"6","author":"Ankad","year":"2016","journal-title":"Dermatol Pract Concept."},{"key":"10.1016\/j.ad.2021.11.002_bib0685","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1177\/1203475416648322","article-title":"Nodular subtype of bullous pemphigoid","volume":"20","author":"Dangel","year":"2016","journal-title":"J Cutan Med Surg."},{"key":"10.1016\/j.ad.2021.11.002_bib0690","first-page":"AB104","article-title":"P2202 Pemphigoid nodularis: Two new cases demonstrating distinguishing clinical clues from prurigo nodularis","author":"Ray","year":"2009","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2021.11.002_bib0695","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2340\/00015555-2492","article-title":"Acquired reactive perforating dermatosis is a variant of prurigo nodularis","volume":"97","author":"Kestner","year":"2017","journal-title":"Acta Derm Venereol."},{"key":"10.1016\/j.ad.2021.11.002_bib0700","article-title":"Dupilumab and prurigo nodularis-like phenotype in atopic dermatitis: our experience of efficacy","author":"Ferrucci","year":"2019","journal-title":"J Dermatolog Treat."},{"key":"10.1016\/j.ad.2021.11.002_bib0705","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/DER.0000000000000517","article-title":"Effectiveness of dupilumab for the treatment of generalized prurigo nodularis phenotype of adult atopic dermatitis","volume":"31","author":"Napolitano","year":"2020","journal-title":"Dermatitis."},{"key":"10.1016\/j.ad.2021.11.002_bib0710","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000358250","article-title":"Extensive prurigo nodularis: Characterization and etiology","volume":"228","author":"Tan","year":"2014","journal-title":"Dermatology."},{"key":"10.1016\/j.ad.2021.11.002_bib0715","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000246715","article-title":"Prurigo nodularis consists of two distinct forms: Early-onset atopic and late-onset non-atopic","volume":"190","author":"Tanaka","year":"1995","journal-title":"Dermatology."},{"key":"10.1016\/j.ad.2021.11.002_bib0720","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jaad.2019.07.022","article-title":"Diagnostic and treatment algorithm for chronic nodular prurigo","volume":"82","author":"St\u00e4nder","year":"2020","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2021.11.002_bib0725","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/cod.12564","article-title":"Contact sensitization in prurigo patients","volume":"75","author":"Weisshaar","year":"2016","journal-title":"Contact Dermatitis."},{"key":"10.1016\/j.ad.2021.11.002_bib0730","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1600-0536.1989.tb03167.x","article-title":"Patch testing in prurigo nodularis","volume":"20","author":"Zelickson","year":"1989","journal-title":"Contact Dermatitis."},{"key":"10.1016\/j.ad.2021.11.002_bib0740","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jaad.2018.09.020","article-title":"A systematic review of evidence-based treatments for prurigo nodularis","volume":"80","author":"Qureshi","year":"2019","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2021.11.002_bib0745","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3109\/09546630903386606","article-title":"An occlusive dressing containing betamethasone valerate 0.1% for the treatment of prurigo nodularis","volume":"21","author":"Saraceno","year":"2010","journal-title":"J Dermatolog Treat."},{"key":"10.1016\/j.ad.2021.11.002_bib0750","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2310\/7750.2009.08082","article-title":"Update on intralesional steroid: Focus on dermatoses","volume":"14","author":"Richards","year":"2010","journal-title":"J Cutan Med Surg."},{"key":"10.1016\/j.ad.2021.11.002_bib0755","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1684\/ejd.2017.3164","article-title":"The use of biodegradable microneedle patches to increase penetration of topical steroid for prurigo nodularis","volume":"28","author":"Shin","year":"2018","journal-title":"Eur J Dermatology."},{"key":"10.1016\/j.ad.2021.11.002_bib0760","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1159\/000355671","article-title":"Evaluation of the antipruritic effects of topical pimecrolimus in non-atopic prurigo nodularis: Results of a randomized, hydrocortisone- controlled, double-blind phase II trial","volume":"227","author":"Siepmann","year":"2014","journal-title":"Dermatology."},{"key":"10.1016\/j.ad.2021.11.002_bib0765","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/archderm.136.6.807","article-title":"Double-blind, right\/left comparison of calcipotriol ointment and betamethasone ointment in the treatment of prurigo nodularis","volume":"136","author":"Wong","year":"2000","journal-title":"Arch Dermatol."},{"key":"10.1016\/j.ad.2021.11.002_bib0770","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1067\/mjd.2001.110059","article-title":"Treatment of prurigo nodularis with topical capsaicin","volume":"44","author":"St\u00e4nder","year":"2001","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2021.11.002_bib0775","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s13555-019-00321-6","article-title":"The neuromodulatory effect of antipruritic treatment of chronic prurigo","volume":"9","author":"Zeidler","year":"2019","journal-title":"Dermatol Ther (Heidelb)."},{"key":"10.1016\/j.ad.2021.11.002_bib0780","series-title":"Clinical cases in phototherapy Cham","first-page":"163","article-title":"Phototherapy for prurigo nodularis","author":"Koo","year":"2017"},{"key":"10.1016\/j.ad.2021.11.002_bib0785","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1365-2133.2010.09858.x","article-title":"Excimer laser vs. clobetasol propionate 0\u00b705% ointment in prurigo form of atopic dermatitis: A randomized controlled trial, a pilot","volume":"163","author":"Brenninkmeijer","year":"2010","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2021.11.002_bib0790","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1600-0781.2008.00328.x","article-title":"Efficacy of UVA1 phototherapy in 230 patients with various skin diseases","volume":"24","author":"Rombold","year":"2008","journal-title":"Photodermatol Photoimmunol Photomed."},{"key":"10.1016\/j.ad.2021.11.002_bib0795","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2230.2009.03705.x","article-title":"Phototherapy of generalized prurigo nodularis","volume":"35","author":"Bruni","year":"2010","journal-title":"Clin Exp Dermatol."},{"key":"10.1016\/j.ad.2021.11.002_bib0800","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1365-2230.2003.01156_7.x","article-title":"Phototherapy in nodular prurigo","volume":"28","author":"Divekar","year":"2003","journal-title":"Clin Exp Dermatol."},{"key":"10.1016\/j.ad.2021.11.002_bib0805","article-title":"Fototerapia en el prurigo nodular Experiencia propia y revisi\u00f3n de la literatura","author":"Arrieta","year":"2020","journal-title":"Actas Dermosifiliogr."},{"key":"10.1016\/j.ad.2021.11.002_bib0810","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1468-3083.2010.03865.x","article-title":"UVB 308-nm excimer light and bath PUVA: Combination therapy is very effective in the treatment of prurigo nodularis","volume":"25","author":"Hammes","year":"2011","journal-title":"J Eur Acad Dermatology Venereol."},{"key":"10.1016\/j.ad.2021.11.002_bib0815","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3109\/09546634.2013.814759","article-title":"Prurigo nodularis: An update on etiopathogenesis and therapy","volume":"24","author":"Fostini","year":"2013","journal-title":"J Dermatolog Treat."},{"key":"10.1016\/j.ad.2021.11.002_bib0820","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/dth.12094","article-title":"Combination therapy of fexofenadine and montelukast is effective in prurigo nodularis and pemphigoid nodularis","volume":"27","author":"Shintani","year":"2014","journal-title":"Dermatol Ther."},{"key":"10.1016\/j.ad.2021.11.002_bib0825","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.clindermatol.2018.08.005","article-title":"Use of antiepileptic mood stabilizers in dermatology","volume":"36","author":"Gupta","year":"2018","journal-title":"Clin Dermatol."},{"key":"10.1016\/j.ad.2021.11.002_bib0830","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1529-8019.2010.01314.x","article-title":"Therapeutic Hotline: Treatment of prurigo nodularis and lichen simplex chronicus with gabapentin","volume":"23","author":"Gencoglan","year":"2010","journal-title":"Dermatol Ther."},{"key":"10.1016\/j.ad.2021.11.002_bib0835","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/jcpt.12005","article-title":"Treatment of prurigo nodularis with pregabalin","volume":"38","author":"Mazza","year":"2013","journal-title":"J Clin Pharm Ther."},{"key":"10.1016\/j.ad.2021.11.002_bib0840","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jaad.2016.02.1237","article-title":"Gabapentin and pregabalin for the treatment of chronic pruritus","volume":"75","author":"Matsuda","year":"2016","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2021.11.002_bib0845","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1681\/ASN.2018010096","article-title":"Gabapentin and pregabalin use and association with adverse outcomes among hemodialysis patients","volume":"29","author":"Ishida","year":"2018","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.ad.2021.11.002_bib0850","first-page":"433","article-title":"Amitriptyline as therapeutic and not symptomatic approach in the treatment of prurigo nodularis: A pilot study","volume":"141","author":"Zalaudek","year":"2006","journal-title":"G Ital Dermatol Venereol."},{"key":"10.1016\/j.ad.2021.11.002_bib0855","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2340\/00015555-0553","article-title":"Treatment of chronic pruritus with the selective serotonin re-uptake inhibitors paroxetine and fluvoxamine: Results of an open-labelled, two-arm proof-of-concept study","volume":"89","author":"St\u00e4nder","year":"2009","journal-title":"Acta Derm Venereol."},{"key":"10.1016\/j.ad.2021.11.002_bib0860","first-page":"533","article-title":"Efficacy and safety of naltrexone, an oral opiate receptor antagonist, in the treatment of pruritus in internal and dermatological diseases","volume":"41","author":"Metze","year":"1999","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2021.11.002_bib0865","doi-asserted-by":"crossref","first-page":"159","DOI":"10.5021\/ad.2016.28.2.159","article-title":"Clinical efficacy and safety of naltrexone combination therapy in older patients with severe pruritus","volume":"28","author":"Lee","year":"2016","journal-title":"Ann Dermatol."},{"key":"10.1016\/j.ad.2021.11.002_bib0870","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2340\/00015555-1353","article-title":"Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: A literature review","volume":"92","author":"Phan","year":"2012","journal-title":"Acta Derm Venereol."},{"key":"10.1016\/j.ad.2021.11.002_bib0875","unstructured":"PRISM Study-Pruritus Relief Through Itch Scratch Modulation - Full Text View - ClinicalTrials.gov [acceso 5 May 2020]. Disponible en: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03497975?cond=%22Prurigo%22&draw=2&rank=12"},{"key":"10.1016\/j.ad.2021.11.002_bib0880","doi-asserted-by":"crossref","DOI":"10.1186\/s12882-015-0043-3","article-title":"Pharmacokinetics of nalbuphine hydrochloride extended release tablets in hemodialysis patients with exploratory effect on pruritus","volume":"16","author":"Hawi","year":"2015","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.ad.2021.11.002_bib0885","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000331577","article-title":"Thalidomide in 42 patients with prurigo nodularis Hyde","volume":"223","author":"Andersen","year":"2011","journal-title":"Dermatology."},{"key":"10.1016\/j.ad.2021.11.002_bib0890","doi-asserted-by":"crossref","first-page":"344","DOI":"10.2340\/00015555-0997","article-title":"Efficacy of thalidomide in the treatment of prurigo nodularis","volume":"91","author":"Taefehnorooz","year":"2011","journal-title":"Acta Derm Venereol."},{"key":"10.1016\/j.ad.2021.11.002_bib0895","unstructured":"Ficha T\u00e9cnica o Resumen de las Caracter\u00edsticas del Producto [consultado 8 May 2020]. Disponible en: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/thalidomide-celgene-epar-product-information_es.pdf."},{"key":"10.1016\/j.ad.2021.11.002_bib0900","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/ced.14015","article-title":"An observational analysis of low-dose thalidomide in recalcitrant prurigo nodularis","volume":"45","author":"Sardana","year":"2020","journal-title":"Clin Exp Dermatol."},{"key":"10.1016\/j.ad.2021.11.002_bib0905","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1346-8138.2007.00260.x","article-title":"Treatment of idiopathic prurigo nodularis in Taiwanese patients with low-dose thalidomide","volume":"34","author":"Lan","year":"2007","journal-title":"J Dermatol."},{"key":"10.1016\/j.ad.2021.11.002_bib0910","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/ced.12365","article-title":"Prurigo nodularis: Retrospective study of 13 cases managed with methotrexate","volume":"39","author":"Spring","year":"2014","journal-title":"Clin Exp Dermatol."},{"key":"10.1016\/j.ad.2021.11.002_bib1010","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/jdv.14646","article-title":"Treatment of prurigo with methotrexate: a multicentre retrospective study of 39 cases","volume":"32","author":"Klejtman","year":"2018","journal-title":"J Eur Acad Dermatology Venereol."},{"key":"10.1016\/j.ad.2021.11.002_bib1015","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jaad.2018.02.024","article-title":"Rapid improvement of prurigo nodularis with cyclosporine treatment","volume":"78","author":"Wiznia","year":"2018","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2021.11.002_bib1020","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.jaad.2017.12.022","article-title":"Dupilumab: A review of its use in the treatment of atopic dermatitis","volume":"78","author":"Gooderham","year":"2018","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2021.11.002_bib1025","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1001\/jamadermatol.2018.3906","article-title":"Reduced itch associated with dupilumab treatment in 4 patients with prurigo nodularis","volume":"155","author":"Mollanazar","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ad.2021.11.002_bib1030","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13201","article-title":"Efficacy of dupilumab in prurigo nodularis in elderly patient","volume":"33","author":"Giura","year":"2020","journal-title":"Dermatol Ther."},{"key":"10.1016\/j.ad.2021.11.002_bib1035","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1001\/jamadermatol.2018.3912","article-title":"Dupilumab treatment for generalized prurigo nodularis","volume":"155","author":"Beck","year":"2019","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.ad.2021.11.002_bib1040","doi-asserted-by":"crossref","first-page":"905","DOI":"10.2340\/00015555-3243","article-title":"Dupilumab in treatment of chronic prurigo: A case series and literature review","volume":"99","author":"Almustafa","year":"2019","journal-title":"Acta Derm Venereol."},{"key":"10.1016\/j.ad.2021.11.002_bib0950","doi-asserted-by":"crossref","first-page":"e303","DOI":"10.1111\/jdv.15584","article-title":"Dramatic improvement of generalized prurigo nodularis with dupilumab","volume":"33","author":"Calugareanu","year":"2019","journal-title":"J Eur Acad Dermatology Venereol."},{"key":"10.1016\/j.ad.2021.11.002_bib0955","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jdcr.2019.03.016","article-title":"Recalcitrant prurigo nodularis treated successfully with dupilumab","volume":"5","author":"Rambhia","year":"2019","journal-title":"JAAD Case Reports."},{"key":"10.1016\/j.ad.2021.11.002_bib1045","first-page":"940","article-title":"Dupilumab treatment for prurigo nodularis and pruritis","volume":"18","author":"Tanis","year":"2019","journal-title":"J Drugs Dermatol."},{"key":"10.1016\/j.ad.2021.11.002_bib1050","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13222","article-title":"Dupilumab for prurigo nodularis: Case series and review of the literature","author":"Holm","year":"2020","journal-title":"Dermatol Ther."},{"key":"10.1016\/j.ad.2021.11.002_bib1055","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1111\/jdv.15957","article-title":"Effectiveness and safety of dupilumab for the treatment of prurigo nodularis in a French multicenter adult cohort of 16 patients","volume":"34","author":"Calugareanu","year":"2020","journal-title":"J Eur Acad Dermatology Venereol."},{"key":"10.1016\/j.ad.2021.11.002_bib1060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2020.03.049","article-title":"Dupilumab improves clinical manifestations, symptoms and quality of life in adult patients with chronic nodular prurigo","author":"Chiricozzi","year":"2020","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2021.11.002_bib1065","unstructured":"Study of dupilumab for the treatment of patients with prurigo nodularis, inadequately controlled on topical prescription therapies or when those therapies are not advisable - Full Text View - ClinicalTrials.gov [acceso 21 Abr 2020]. Disponible en: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04183335?cond=prurigo&draw=3&rank=16."},{"key":"10.1016\/j.ad.2021.11.002_bib1070","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1056\/NEJMoa1908316","article-title":"Trial of nemolizumab in moderate-to-severe prurigo nodularis","volume":"382","author":"St\u00e4nder","year":"2020","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ad.2021.11.002_bib1075","unstructured":"Long-term safety and efficacy of nemolizumab with moderate-to-severe atopic dermatitis - Full Text View - ClinicalTrials.gov [acceso 21 Abr 2020]. Disponible en: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03989206?term=nemolizumab&draw=2&rank=2"},{"key":"10.1016\/j.ad.2021.11.002_bib1080","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2340\/00015555-3120","article-title":"Aprepitant in anti-histamine-refractory chronic nodular prurigo: A multicentre, randomized, double-blind, placebo-controlled, cross-over, phase-II trial (APREPRU)","volume":"99","author":"Tsianakas","year":"2019","journal-title":"Acta Derm Venereol."},{"key":"10.1016\/j.ad.2021.11.002_bib1085","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.jaad.2019.01.052","article-title":"Serlopitant reduced pruritus in patients with prurigo nodularis in a phase 2, randomized, placebo-controlled trial","volume":"80","author":"St\u00e4nder","year":"2019","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2021.11.002_bib1005","unstructured":"Vixarelimab (KPL-716) Phase 2a Prurigo Nodularis Data [accesos 10 Oct 2020]. DIsponible en: https:\/\/www.sec.gov\/Archives\/edgar\/data\/1730430\/000110465920049520\/tm2016542d1_ex99-2.htm"},{"key":"10.1016\/j.ad.2021.11.002_bib1090","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3461","article-title":"Efficacy of apremilast in patients with prurigo nodularis: A proof-of-concept study","author":"Todberg","year":"2020","journal-title":"Acta Derm Venereol."}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731021004257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731021004257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T01:14:10Z","timestamp":1757553250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731021004257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":100,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0001731021004257"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2021.11.002","relation":{},"ISSN":["0001-7310"],"issn-type":[{"value":"0001-7310","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prurigo cr\u00f3nico: actualizaci\u00f3n","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2021.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 AEDV. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}